VIMBECELLIA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

VIMBECELLIA Trademark

Serial Number: 90151771 • Registration: 6841829

VIMBECELLIA is a trademark filed by ASCENTAGE PHARMA (SUZHOU) CO., LTD. on September 1, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ASCENTAGE PHARMA (SUZHOU) CO., LTD. (23 trademarks)

68 XINQING ROAD
SUZHOU 215000 , CN

Entity Type: 03

ASCENTAGE PHARMA GROUP CORP LIMITED (13 trademarks)

9/F, Wah Yuen Building
Hong Kong 999077 , CN

Entity Type: 03

Trademark Details

Filing Date

September 1, 2020

Registration Date

September 13, 2022

Published for Opposition

June 28, 2022

Goods & Services

Medicines for dental purposes; Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antiseptics; Collyrium; Hemorrhoidal suppositories, laxative suppositories, or vaginal suppositories for the prevention and treatment of infections; Medical paster, namely, medical plasters; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Medicated sweets; Candy for medical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic preparations adapted for medical purposes; Medicinal oils; Mineral food supplements; Nutritional supplements; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Radioactive substances for medical purposes; Gases for medical purposes, namely, nitric oxide for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Solutions for contact lenses; Media for bacteriological cultures; Depuratives for the body; Diagnostic preparations for veterinary purposes; Pesticides; Sanitary napkins; Cotton for medical purposes; Dental abrasives; Diapers for pets

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 2, 2025 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2022 CRFA
ASSIGNED TO LIE
May 17, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 12, 2022 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 24, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 24, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
May 24, 2021 GNSL
SUSPENSION LETTER WRITTEN
May 24, 2021 CNSL
ASSIGNED TO EXAMINER
May 12, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2021 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2020 NWOS
NEW APPLICATION ENTERED
Sep 4, 2020 NWAP